BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17274524)

  • 1. Molecular basis of neurodegenerative diseases.
    Rotilio J; Stella AM
    Ital J Biochem; 2006; 55(3-4):189-93. PubMed ID: 17274524
    [No Abstract]   [Full Text] [Related]  

  • 2. ER stress and neurodegenerative diseases.
    Lindholm D; Wootz H; Korhonen L
    Cell Death Differ; 2006 Mar; 13(3):385-92. PubMed ID: 16397584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing therapeutics for the diseases of protein misfolding.
    May BC; Govaerts C; Cohen FE
    Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diseases associated with protein aggregation].
    Bak D; Milewski M
    Postepy Biochem; 2005; 51(3):297-307. PubMed ID: 16381174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The environmental dependency of protein folding best explains prion and amyloid diseases.
    Kelly JW
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):930-2. PubMed ID: 9448261
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of chaperones in Parkinson's disease and prion diseases.
    Winklhofer KF; Tatzelt J
    Handb Exp Pharmacol; 2006; (172):221-58. PubMed ID: 16610362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseases.
    Thompson AJ; Barrow CJ
    Curr Med Chem; 2002 Oct; 9(19):1751-62. PubMed ID: 12369885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS; Kozuka Y; Kaneko K
    Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of extracellular chaperones in amyloidosis.
    Wyatt AR; Yerbury JJ; Dabbs RA; Wilson MR
    J Mol Biol; 2012 Aug; 421(4-5):499-516. PubMed ID: 22248589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein folding and cutaneous diseases.
    Botelho MG; Lupi O
    Int J Dermatol; 2008 Dec; 47(12):1225-33. PubMed ID: 19126006
    [No Abstract]   [Full Text] [Related]  

  • 12. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
    Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
    Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein misfolding, evolution and disease.
    Dobson CM
    Trends Biochem Sci; 1999 Sep; 24(9):329-32. PubMed ID: 10470028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chaperono- and proteinopathies: molecular basis--novel therapeutic options].
    Maier CP
    Dtsch Med Wochenschr; 2008 Apr; 133(15):777-81. PubMed ID: 18382952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Approaches from genetical analyses on human diseases: neurodegenerative diseases].
    Kakizuka A
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):792-7. PubMed ID: 10771635
    [No Abstract]   [Full Text] [Related]  

  • 16. The attention of researchers on the biological process of protein folding has turned to the formation and properties of aggregates.
    Ellis RJ
    Semin Cell Dev Biol; 2004 Feb; 15(1):1-2. PubMed ID: 15036201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparan sulphates, amyloidosis and neurodegeneration].
    Vera C; Alvarez-Orozco JA; Maiza A; Chantepie S; Chehin RN; Ouidja MO; Papy-Garcia D
    Rev Neurol; 2017 Nov; 65(10):457-468. PubMed ID: 29130469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
    Coleman BM; Nisbet RM; Han S; Cappai R; Hatters DM; Hill AF
    Biochem Biophys Res Commun; 2009 Mar; 380(3):564-8. PubMed ID: 19285001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of J proteins in neurodegenerative disorders.
    Gibbs SJ; Braun JE
    Neurobiol Dis; 2008 Nov; 32(2):196-9. PubMed ID: 18760363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic disorder in proteins associated with neurodegenerative diseases.
    Uversky VN
    Front Biosci (Landmark Ed); 2009 Jun; 14(14):5188-238. PubMed ID: 19482612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.